FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2782299529> ?p ?o ?g. }

• W2782299529 endingPage "61" @default.
• W2782299529 startingPage "61" @default.
• W2782299529 abstract "Autologous platelet rich plasma (PRP) is used increasingly in a variety of settings. PRP injections have been used for decades to improve angiogenesis and wound healing. They have also been offered commercially in urology with little to no data on safety or efficacy. PRP could theoretically improve multiple urologic conditions, such as erectile dysfunction (ED), Peyronie's disease (PD), and stress urinary incontinence (SUI). A concern with PRP, however, is early washout, a situation potentially avoided by conversion to platelet rich fibrin matrix (PRFM). Before clinical trials can be performed, safety analysis is desirable. We reviewed an initial series of patients receiving PRFM for urologic pathology to assess safety and feasibility.Data were reviewed for patients treated with PRFM at our center from November 2012 to July 2017. Patients were observed immediately post-injection and at follow-up for complications and tolerability. Where applicable, International Index of Erectile Function (IIEF-5) scores were reviewed before and after injections for ED and/or PD. Pad use data was collected pre/post injection for SUI.Seventeen patients were identified, with a mean receipt of 2.1 injections per patient. Post-procedural minor adverse events were seen in 3 men, consisting of mild pain at injection site and mild penile bruising. No patients experienced complications at follow-up. No decline was observed in men completing pre/post IIEF-5 evaluations.PRFM appears to be a safe and feasible treatment modality in patients with urologic disease. Further placebo-controlled trials are warranted." @default.
• W2782299529 created "2018-01-12" @default.
• W2782299529 creator A5031937587 @default.
• W2782299529 creator A5042562482 @default.
• W2782299529 creator A5075778918 @default.
• W2782299529 date "2018-01-01" @default.
• W2782299529 modified "2023-10-13" @default.
• W2782299529 title "Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions" @default.
• W2782299529 cites W1615938083 @default.
• W2782299529 cites W186825205 @default.
• W2782299529 cites W1931315964 @default.
• W2782299529 cites W1943230436 @default.
• W2782299529 cites W1964298525 @default.
• W2782299529 cites W1982890562 @default.
• W2782299529 cites W2003328261 @default.
• W2782299529 cites W2025503607 @default.
• W2782299529 cites W2032500729 @default.
• W2782299529 cites W2033842599 @default.
• W2782299529 cites W2041323597 @default.
• W2782299529 cites W2042301462 @default.
• W2782299529 cites W2043215269 @default.
• W2782299529 cites W2057190712 @default.
• W2782299529 cites W2063570212 @default.
• W2782299529 cites W2074716378 @default.
• W2782299529 cites W2092212173 @default.
• W2782299529 cites W2100461064 @default.
• W2782299529 cites W2116689466 @default.
• W2782299529 cites W2124525370 @default.
• W2782299529 cites W2150211787 @default.
• W2782299529 cites W2159818171 @default.
• W2782299529 cites W2167938512 @default.
• W2782299529 cites W2326832766 @default.
• W2782299529 cites W26912359 @default.
• W2782299529 cites W2796266870 @default.
• W2782299529 cites W36309341 @default.
• W2782299529 doi "https://doi.org/10.4111/icu.2018.59.1.61" @default.
• W2782299529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5754585" @default.
• W2782299529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29333517" @default.
• W2782299529 hasPublicationYear "2018" @default.
• W2782299529 type Work @default.
• W2782299529 sameAs 2782299529 @default.
• W2782299529 citedByCount "75" @default.
• W2782299529 countsByYear W27822995292018 @default.
• W2782299529 countsByYear W27822995292019 @default.
• W2782299529 countsByYear W27822995292020 @default.
• W2782299529 countsByYear W27822995292021 @default.
• W2782299529 countsByYear W27822995292022 @default.
• W2782299529 countsByYear W27822995292023 @default.
• W2782299529 crossrefType "journal-article" @default.
• W2782299529 hasAuthorship W2782299529A5031937587 @default.
• W2782299529 hasAuthorship W2782299529A5042562482 @default.
• W2782299529 hasAuthorship W2782299529A5075778918 @default.
• W2782299529 hasBestOaLocation W27822995291 @default.
• W2782299529 hasConcept C126322002 @default.
• W2782299529 hasConcept C126894567 @default.
• W2782299529 hasConcept C141071460 @default.
• W2782299529 hasConcept C142724271 @default.
• W2782299529 hasConcept C197934379 @default.
• W2782299529 hasConcept C203014093 @default.
• W2782299529 hasConcept C204787440 @default.
• W2782299529 hasConcept C27081682 @default.
• W2782299529 hasConcept C2777560349 @default.
• W2782299529 hasConcept C2778375690 @default.
• W2782299529 hasConcept C2779929075 @default.
• W2782299529 hasConcept C2780076745 @default.
• W2782299529 hasConcept C535046627 @default.
• W2782299529 hasConcept C54173615 @default.
• W2782299529 hasConcept C71924100 @default.
• W2782299529 hasConcept C89560881 @default.
• W2782299529 hasConceptScore W2782299529C126322002 @default.
• W2782299529 hasConceptScore W2782299529C126894567 @default.
• W2782299529 hasConceptScore W2782299529C141071460 @default.
• W2782299529 hasConceptScore W2782299529C142724271 @default.
• W2782299529 hasConceptScore W2782299529C197934379 @default.
• W2782299529 hasConceptScore W2782299529C203014093 @default.
• W2782299529 hasConceptScore W2782299529C204787440 @default.
• W2782299529 hasConceptScore W2782299529C27081682 @default.
• W2782299529 hasConceptScore W2782299529C2777560349 @default.
• W2782299529 hasConceptScore W2782299529C2778375690 @default.
• W2782299529 hasConceptScore W2782299529C2779929075 @default.
• W2782299529 hasConceptScore W2782299529C2780076745 @default.
• W2782299529 hasConceptScore W2782299529C535046627 @default.
• W2782299529 hasConceptScore W2782299529C54173615 @default.
• W2782299529 hasConceptScore W2782299529C71924100 @default.
• W2782299529 hasConceptScore W2782299529C89560881 @default.
• W2782299529 hasIssue "1" @default.
• W2782299529 hasLocation W27822995291 @default.
• W2782299529 hasLocation W27822995292 @default.
• W2782299529 hasLocation W27822995293 @default.
• W2782299529 hasLocation W27822995294 @default.
• W2782299529 hasLocation W27822995295 @default.
• W2782299529 hasOpenAccess W2782299529 @default.
• W2782299529 hasPrimaryLocation W27822995291 @default.
• W2782299529 hasRelatedWork W1966047811 @default.
• W2782299529 hasRelatedWork W2003042623 @default.
• W2782299529 hasRelatedWork W202460821 @default.
• W2782299529 hasRelatedWork W2103976958 @default.
• W2782299529 hasRelatedWork W2124216954 @default.

• next